Search

The Mediterranean Diet (MedDiet) has been promoted as a means of preventing and treating cardiodiabesity. The aim of this study was to answer a number of key clinical questions (CQs) about the role of the MedDiet in cardiodiabesity in order to provide a framework for the development of clinical practice guidelines. A systematic review was conducted to answer five CQs formulated using the Patient, Intervention, Comparison, and Outcome (PICO) criteria. Twenty articles published between September 2013 and July 2016 were included, adding to the 37 articles from the previous review. There is a high level of evidence showing that MedDiet adherence plays a role in the primary and secondary prevention of cardiovascular disease (CVD) and improves health in overweight and obese patients. There is moderate-to-high evidence that the MedDiet prevents increases in weight and waist circumference in non-obese individuals, and improves metabolic syndrome (MetS) and reduces its incidence. Finally, there is moderate evidence that the MedDiet plays primary and secondary roles in the prevention of type 2 diabetes mellitus (T2DM). The MedDiet is effective in preventing obesity and MetS in healthy and at-risk individuals, in reducing mortality risk in overweight or obese individuals, in decreasing the incidence of T2DM and CVD in healthy individuals, and in reducing symptom severity in individuals with T2DM or CVD.

The Mediterranean Diet (MedDiet) has been promoted as a means of preventing and treating cardiodiabesity. The aim of this study was to answer a number of key clinical questions (CQs) about the role of the MedDiet in cardiodiabesity in order to provide a framework for the development of clinical practice guidelines. A systematic review was conducted to answer five CQs formulated using the Patient, Intervention, Comparison, and Outcome (PICO) criteria. Twenty articles published between September 2013 and July 2016 were included, adding to the 37 articles from the previous review. There is a high level of evidence showing that MedDiet adherence plays a role in the primary and secondary prevention of cardiovascular disease (CVD) and improves health in overweight and obese patients. There is moderate-to-high evidence that the MedDiet prevents increases in weight and waist circumference in non-obese individuals, and improves metabolic syndrome (MetS) and reduces its incidence. Finally, there is moderate evidence that the MedDiet plays primary and secondary roles in the prevention of type 2 diabetes mellitus (T2DM). The MedDiet is effective in preventing obesity and MetS in healthy and at-risk individuals, in reducing mortality risk in overweight or obese individuals, in decreasing the incidence of T2DM and CVD in healthy individuals, and in reducing symptom severity in individuals with T2DM or CVD.

L'alimentació poc saludable i la falta d'exercici físic són les principals causes de malalties no transmissibles, com per exemple les patologies cardiovasculars. Aquest estudi té com a objectiu conèixer el grau d'adherència a la dieta mediterrània i els factors determinants de la prevalença dels risc de cardiodiabesitat en els treballadors d'un hospital general. Estudi de recerca de tipus descriptiu, que parteix d'una cohort constituïda pels treballadors/res que es van realitzar un examen de salut laboral en el període de 1 de gener del 2017 a 24 de maig del 2018. Es va realitzar una anàlisi descriptiva segons variables socials i ocupacionals. Unhealthy diets and lack of physical activity are the main causes of communicable diseases, such as cardiovascular diseases. This study aims to assess the degree of adherence to the Mediterranean diet among workers of a general hospital and analyze the prevalence factors for "cardiodiobesity" risk in this population. A descriptive study, based on a cohort of workers examined in an occupational health examination in from January 1, 2017 to May 24, 2018. A descriptive analysis was carried out according to social and occupational variables. La alimentación poco saludable y la falta de ejercicio físico son las principales causas de enfermedades no transmisibles, como por ejemplo las patologías cardiovasculares. Este estudio tiene como objetivo conocer el grado de adherencia a la dieta mediterránea y los factores determinantes de la prevaléncia de los riesgo de cardiodiabesitat en los trabajadores de un hospital general. Estudio de investigación de tipo descriptivo, que parte de una cohort constituida por los trabajadores/nada que se realizaron un examen de salud laboral en el periodo de 1 de enero del 2017 a 24 de mayo del 2018. Se realizó un análisis descriptivo según variables sociales y ocupacionales.

Cardiodiabesity has been used to define and describe the well-known relationship between type 2 Diabetes Mellitus (T2DM), obesity, the metabolic syndrome (MetS) and cardiovascular disease (CVD). The objective of this study was to perform a scientific literature review with a systematic search to examine all the cardiovascular risk factors combined and their relationship with adherence to the Mediterranean Diet (MedDiet) pattern as primary prevention against cardiodiabesity in a holistic approach. Research was conducted using the PubMed database including clinical trials, cross-sectional and prospective cohort studies. Thirty-seven studies were reviewed: fourteen related to obesity, ten to CVD, nine to MetS, and four to T2DM. Indeed 33 provided strong evidence on the association between adherence to a MedDiet and a reduced incidence of collective cardiodiabesity risk in epidemiological studies. This scientific evidence makes the MedDiet pattern very useful for preventive strategies directed at the general population and also highlights the need to consider all these diet-related risk factors and health outcomes together in daily primary care.